Jtnl Llc Pharmaceutical Import Profile — Russia (DGFT 2022–2026)

Name: Jtnl Llc Pharmaceutical Import Records from India — 2 Products, $6.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Jtnl Llc — Pharmaceutical Importer Profile (2026) | 2 Products, $6.6M Trade | TransData Nexus

Jtnl Llc

Pharmaceutical Importer · Russia · Respiratory & OTC Focus · $6.6M Total Trade · DGFT Verified

Jtnl Llc is a pharmaceutical importer based in Russia with a total trade value of $6.6M across 2 products in 2 therapeutic categories. Based on 601 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Jtnl Llc sources from 2 verified Indian suppliers, with J B Chemicals And Pharmaceuticals Limited accounting for 92.3% of imports.

Jtnl Llc — Import Portfolio & Supplier Network

Jtnl Llc import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Jtnl Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
J B Chemicals And Pharmaceuticals Limited	$8.2M	752	92.3%
J B Chemicals Pharmaceuticals Limited	$688.6K	39	7.7%

Jtnl Llc sources from 2 verified Indian suppliers across .

What Formulations Does Jtnl Llc Import?

Formulation	Value	Ships
Dmhcl lemon 5 x 4 rus	$444.6K	31
Doktor mom herbal cough syp 150ML rus	$427.2K	18
Mgl denta gel tube 20GM rus exp	$373.1K	29
Rinza tablets.Each tablet contains caffeine anhydrous powder 30MG and paracetamol BP 500MG rinza tabs 2x10 rus exp	$319.4K	9
Dmhcl raspberry 5 x 4 rus	$297.7K	21
Mgl denta gel tube 20GM	$290.5K	11
Rinza sip with vitamin c flavour lemon Each sachet of 5GM contains caffeine anhydrous powder 30MG rinza sip+vit c	$232.8K	11
Dmhcs 100ML rus exp	$230.4K	9
Rinza sip with vitamin c flavour lemon .Each sachet of 5GM contains caffeine anhydrous powder 30MG rinza sip+vit c	$228.7K	10
Dmhcl orange 5 x 4 rus	$198.1K	15
Doktor mom herbal cough syrup 150ML	$192.4K	5
Dmhcl berries 5 x 4 rus	$186.0K	11
Rinza sip with vitamin c flavour orange.Each sachet of 5GM contains caffeine anhydrous powder 30MG rinza sip+vit	$172.7K	17
Rinza sip with vitamin c flavour lemon.Each sachet of 5GM contains caffeine anhydrous powder 30MG rinza sip+vit c	$141.7K	9
Rinza sip with vitamin c flavour orangeeach sachet of 5GM contains caffeine anhydrous powder 30MG rinza sip+vit	$141.5K	11

Jtnl Llc imports 306 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Caffeine	Respiratory & OTC	$4.5M	452	4.2%	3
2	Vitamin	Nutritional Supplements	$2.1M	149	1.5%	8

Jtnl Llc imports 2 pharmaceutical products across 2 categories into Russia totaling $6.6M.

Jtnl Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Jtnl Llc is a Russian pharmaceutical importer specializing in the acquisition of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Headquartered in Moscow, Russia, the company plays a significant role in the distribution of imported pharmaceutical products within the Russian market. While specific details about its parent company are not publicly available, Jtnl Llc's operations are integral to the pharmaceutical supply chain in Russia, facilitating access to a diverse range of medications for various therapeutic needs.

2Distribution Network

Jtnl Llc's distribution network is centered in Moscow, serving as a strategic hub for the import and distribution of pharmaceutical products across Russia. The company's logistics capabilities are designed to ensure efficient delivery of imported medications to various regions within the country. While specific warehouse locations and geographic coverage details are not publicly disclosed, Moscow's position as a major logistical center in Russia suggests that Jtnl Llc's operations are well-positioned to meet the pharmaceutical needs of the Russian market.

3Industry Role

In Russia's pharmaceutical supply chain, Jtnl Llc functions primarily as a pharmaceutical importer, sourcing finished pharmaceutical formulations from international suppliers and distributing them within the Russian market. The company's role is crucial in ensuring the availability of a wide range of medications, thereby supporting the healthcare system's capacity to meet diverse patient needs. By importing and distributing these products, Jtnl Llc contributes to the overall accessibility and diversity of pharmaceutical options available to healthcare providers and patients in Russia.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Jtnl Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Jtnl Llc demonstrates a high level of sourcing concentration, with a significant majority of its imports originating from a single supplier, J B Chemicals and Pharmaceuticals Limited. This supplier accounts for approximately 92.3% of the total import value, indicating a strong and possibly strategic partnership. The remaining 7.7% of imports are sourced from J B Chemicals Pharmaceuticals Limited, suggesting a reliance on a limited number of suppliers. This concentration could present risks related to supply chain disruptions or changes in supplier dynamics. However, the stability and reliability of these supplier relationships appear to be well-established, as evidenced by the consistent volume of shipments over time.

2Supply Chain Resilience

Jtnl Llc's supply chain resilience is closely tied to its sourcing strategy, which is heavily dependent on a limited number of suppliers. The company's import portfolio includes 306 unique formulations, indicating a diverse range of products. However, the concentration of imports from a single supplier suggests potential vulnerabilities in the supply chain. To mitigate these risks, it would be prudent for Jtnl Llc to consider diversifying its supplier base and establishing relationships with additional manufacturers. This approach would enhance supply chain resilience and reduce the impact of potential disruptions from any single supplier.

Importing Pharmaceuticals into Russia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Russia

1Regulatory Authority & Framework

The primary regulatory authority overseeing the importation and distribution of pharmaceutical products in Russia is the Ministry of Health of the Russian Federation. The key legislation governing pharmaceutical imports is Federal Law No. 61-FZ "On the Circulation of Medicines," enacted on April 12, 2010. This law establishes the procedures for the importation, registration, and circulation of medicinal products within Russia. The law outlines the requirements for obtaining import licenses, conducting clinical trials, and ensuring the safety, efficacy, and quality of medicinal products. Additionally, the Eurasian Economic Union (EAEU) regulations play a role in harmonizing standards and procedures for pharmaceutical imports among member states, including Russia.

2Import Licensing & GMP

Import licensing in Russia is governed by Federal Law No. 61-FZ, which stipulates that entities wishing to import medicinal products must obtain an import license from the Ministry of Health. This process involves submitting an application that includes detailed information about the medicinal products, their intended use, and compliance with Russian standards. Regarding Good Manufacturing Practice (GMP) certification, Russia recognizes GMP certificates from the European Union (EU GMP), the World Health Organization (WHO GMP), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must ensure that their suppliers hold valid GMP certifications from these recognized bodies to facilitate the importation process. Additionally, wholesale distribution authorization is required for entities involved in the distribution of medicinal products within Russia, ensuring compliance with national regulations and standards.

Jtnl Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Jtnl Llc's product strategy focuses on importing finished pharmaceutical formulations, with a particular emphasis on products in the Respiratory & OTC and Nutritional Supplements therapeutic categories. The company's top two imported products are Caffeine and Vitamin, which together account for 100% of its import portfolio. This strategic focus suggests that Jtnl Llc is targeting specific market segments within Russia, likely driven by consumer demand for over-the-counter respiratory treatments and nutritional supplements. The choice to import these specific therapeutic areas may be influenced by factors such as market trends, consumer health needs, and the availability of these products from international suppliers.

2Sourcing Profile

Jtnl Llc's sourcing strategy is characterized by a high degree of concentration, with the majority of its imports originating from a single supplier, J B Chemicals and Pharmaceuticals Limited. This approach may offer benefits such as favorable pricing and streamlined logistics. However, it also exposes the company to risks associated with supplier dependency, including potential supply chain disruptions or shifts in supplier priorities. To mitigate these risks, Jtnl Llc may consider diversifying its supplier base and establishing relationships with additional manufacturers, thereby enhancing supply chain resilience and reducing the impact of potential disruptions from any single supplier.

Market Positioning

Seller's Guide — How to Become a Supplier to Jtnl Llc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter Jtnl Llc's supply chain, particularly if they can offer competitive pricing, reliable quality, and the ability to meet the company's specific product requirements. Diversifying Jtnl Llc's supplier base could lead to a more robust and flexible supply chain, benefiting both the importer and potential new suppliers. For Indian exporters, establishing a partnership with Jtnl Llc could provide access to the Russian pharmaceutical market, leveraging the existing distribution network and market presence of the importer.

2Requirements & Qualifications

Indian exporters seeking to supply Jtnl Llc and the Russian market must ensure that their products comply with Russian regulations, including obtaining the necessary import licenses and adhering to quality standards. Products must be registered in Russia, and manufacturers should hold valid GMP certifications recognized by Russian authorities. Additionally, labeling must be in Russian, providing essential information such as the product's name, dosage form, strength, manufacturer details, and usage instructions. Compliance with these requirements is essential for successful market entry and distribution within Russia.

How to Approach

Frequently Asked Questions — Jtnl Llc

What products does Jtnl Llc import from India?

Jtnl Llc imports 2 pharmaceutical products across 2 categories. Top imports: Caffeine ($4.5M), Vitamin ($2.1M).

Who supplies pharmaceuticals to Jtnl Llc from India?

Jtnl Llc sources from 2 verified Indian suppliers. The primary supplier is J B Chemicals And Pharmaceuticals Limited (92.3% of imports, $8.2M).

What is Jtnl Llc's total pharmaceutical import value?

Jtnl Llc's total pharmaceutical import value from India is $6.6M, based on 601 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Jtnl Llc focus on?

Jtnl Llc imports across 2 categories. The largest: Respiratory & OTC (68.5%), Nutritional Supplements (31.5%).

Get Full Jtnl Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.